U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma Life Science Investing
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Pharmaceutical Investing
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Pharmaceutical Investing
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Pharmaceutical Investing
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Pharmaceutical Investing
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Pharmaceutical Investing
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters Medical Device Investing
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters Medical Device Investing
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters Medical Device Investing
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters Medical Device Investing
Medtronic announces first surgery with Hugo robotic-assisted surgery system in the U.S. performed at Cleveland Clinic Medical Device Investing
Medtronic announces first surgery with Hugo robotic-assisted surgery system in the U.S. performed at Cleveland Clinic Medical Device Investing
